Skip to Main Content

Try STAT+ TODAY

HIV

Learn more about HIV, including its history, transmission, treatment and prevention, and read the latest on new research and drugs.

Most Read

Health Helen Branswell

Patient Zero in AIDS crisis was misidentified, study says, rewriting early history of virus

Health Helen Branswell and Patrick Skerrett

As Charlie Sheen now knows, HIV today isn’t a death sentence

Health Bernard Weinraub

Watch: Charlie Sheen’s doctor wants you to know he’s no Hollywood quack

Health Ike Swetlitz

HIV drugs protect against transmission, even in unprotected sex

In the Lab Karen Weintraub

Four ways chimps have helped medical research

Pharmalot Ed Silverman

Gilead’s new price hikes on HIV drugs anger AIDS activists

Health Erin Mershon

Insurer’s mailing to customers made HIV status visible through envelope window

Health Jennifer Adaeze Okwerekwu

HIV infection makes people five years older at a cellular level

All Coverage

Pharmalot Ed Silverman

STAT Plus: ViiV will make it easier for generic companies to copy its HIV prevention shot, but it’s not clear when

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Pfizer to merge off-patent business with Mylan; conservatives try to sabotage Trump pricing plan

advertisement

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Glaxo is set to hire a new chairman; Gilead tries to bulk up with new deal

Pharmalot Ed Silverman

STAT Plus: AIDS groups criticize Express Scripts for excluding several HIV medicines

Pharmalot Ed Silverman

STAT Plus: Gilead will donate Truvada for HIV prevention, but reaction is mixed

Pharmalot Ed Silverman

STAT Plus: Once-a-day pills for combating HIV are a better deal than some people think

Pharmalot Ed Silverman

STAT Plus: Gilead’s HIV prevention pill can greatly reduce new infections in targeted rollouts

Business Lev Facher and Ike Swetlitz

Aetna faces class-action lawsuit over HIV disclosures

Health Bob Tedeschi

Homeless and sick, he ended up in a place where loved ones could find him

In the Lab Sharon Begley

CRISPR identifies genes that might be targeted to hobble HIV infection

Pharmalot Ed Silverman

Gilead asks FDA to expand exclusivity for a key HIV drug

In the Lab Andrew Joseph

A drug used to treat Crohn’s disease could suppress HIV, monkey study suggests

Health Dylan Scott

In Trump’s America, towns in poor health don’t think he will save them

Heavyweights Rebecca Robbins

The drug pricing crusader at the center of one of the nastiest fights of the election season

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: FDA approves a biosimilar version of Enbrel

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Glaxo believes its plan for HIV treatment is a ‘game changer’

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Another analysis finds new cholesterol drugs are not cost-effective

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Gilead’s preventive HIV pill must be covered in England

Health Lindzi Wessel

High rates of injection drug use increases gay teens’ HIV risk

Business Rebecca Robbins

Gilead hikes price of HIV therapies, other drugs by up to 10 percent

In the Lab Eric Boodman

Inside a monkey lab, research gets fast-tracked in the ‘Zika room’

First Opinion Benjamin Mazer

We are not viruses: Don’t limit gay men from donating blood

First Opinion Anthony S. Fauci and Deborah L. Birx

An AIDS-free world is possible, but do we have the will to achieve it?

Health Helen Branswell

HIV rates soar among Southern men who have sex with men

Health Leah Samuel

World’s first transplant of HIV-positive liver a success, doctors say